Zacks Investment Research on MSN
Is trending stock Abbott Laboratories (ABT) a buy now?
Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...
Abbott Laboratories will invest $40 million over five years into its highly-scrutinized Michigan plant to resolve stockholder ...
The latest chapter in an ongoing legal battle between Abbott Laboratories and parents of babies born prematurely is slated to ...
Jury selection in Cook County is set to kick off this week in a closely watched courtroom battle over Abbott Laboratories’ ...
Opening arguments begin in first Illinois trial against Abbott over its formula for premature babies
Attorneys for parents and Abbott Laboratories faced off during opening arguments Monday in the first Chicago trial over ...
StockStory.org on MSN
Q4 earnings highs and lows: Abbott Laboratories (NYSE:ABT) vs the rest of the medical devices & supplies - diversified stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...
Abbott Laboratories saw its shares down 10% at the end of trading Thursday, Jan. 22, as the market digested weaknesses from its fourth-quarter and full-year earnings report. Overall, fourth-quarter ...
Abbott Laboratories’ modelled fair value has been adjusted only fractionally, from US$133.39 to US$133.33 per share, keeping ...
Shares of Abbott Laboratories ABT shed 1.33% to $109.56 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 1.33% to 6,740.02 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results